Comparing dose response of cancer incidence in Sweden after the Chernobyl Nuclear Power Plant accident with Life Span Study of atomic bomb survivors

比较切尔诺贝利核电站事故后瑞典癌症发病率的剂量反应与原子弹幸存者寿命研究

阅读:1

Abstract

Follow-up of the atomic bomb survivors in Japan in the Life Span Study (LSS) has been fundamental for the understanding of the dose-response curve. We compare our risk estimates from a newly published epidemiological study on cancer in Sweden after the Chernobyl Nuclear Power Plant accident with the LSS data. Hazard ratios (HRs) with 95% confidence intervals (95% CIs) were calculated using conditional logistic regression adjusted for rural/nonrural habitat, education level, and pre-Chernobyl cancer incidence from 1980 to 1985, respectively. Adjusted HRs by sex were calculated in deciles for all cancer sites combined for 1986 to 2020. These risk estimates were translated to excess relative risk (ERR) to allow comparison with LSS incidence data. ERRs per decile were compatible with ERR in the low-dose range <100 mGy for both sexes. The CIs in each decile need to be taken into account when interpreting the dose-response curve. Risk estimates in dose categories add important information at very low doses on the dose-response curve when compared to LSS data.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。